# OnCo record paper-gog-174-methotrexate-vs-dactinomycin-low-risk-gtn-jco-2011 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gog-174-methotrexate-vs-dactinomycin-low-risk-gtn-jco-2011/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gog-174-methotrexate-vs-dactinomycin-low-risk-gtn-jco-2011" ;
  schema:name "GOG 174: weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia"@en ;
  schema:description "In the only large randomised comparison of the two standard single drugs for low-risk GTN, dactinomycin given once a fortnight cured more women than weekly methotrexate, though both were followed by successful rescue in almost everyone."@en ;
  schema:url <https://onco.cc/key-papers/paper-gog-174-methotrexate-vs-dactinomycin-low-risk-gtn-jco-2011/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2010.30.4386>, <https://pubmed.ncbi.nlm.nih.gov/21263100/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2010.30.4386> ;
  schema:datePublished "2011"^^xsd:gYear ;
  schema:author "Osborne RJ, Filiaci V, Schink JC, et al." ;
  onco:cancers <https://onco.cc/cancers/low-risk-gtn/> ;
  onco:drugs <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/dactinomycin/> ;
  onco:journals <https://onco.cc/journals/jco/> .